Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental Disorders Article DOI:
10.1007/s10803-005-3306-1 Cite this article as: Hardan, A.Y., Jou, R.J. & Handen, B.L. J Autism Dev Disord (2005) 35: 387. doi:10.1007/s10803-005-3306-1 Abstract
A retrospective study was conducted in a clinic specialized in treating individuals with developmental disabilities to examine the effectiveness and tolerability of quetiapine in children and adolescents with pervasive developmental disorders. Ten consecutive outpatients (age = 12.0 ± 5.1 years) treated with quetiapine (dose = 477 ± 212 mg, duration = 22.0 ± 10.1 weeks) were identified and six were judged to be responders based on impressions from chart review and Conners Parent Scale (CPS). Improvements were observed in the conduct, inattention, and hyperactivity subscales of the CPS. Adverse events were mild with sedation being the most common, and no patient required treatment termination. Quetiapine may be beneficial in children and adolescents with pervasive developmental disorders, however open-label and double-blind, placebo-controlled studies are warranted.
Keywords Quetiapine antipsychotic agents autism pervasive developmental disorder children adolescents References Adityanee, A. M., Schulz, S. C. 2002 Clinical use of quetiapine in disease states other than schizophrenia Journal of Clinical Psychiatry 63 32 38 Google Scholar Arvanitis, L. A., Miller, B. G. 1997 Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo The Seroquel Trial 13 Study Group. Biological Psychiatry 42 233 246 Google Scholar David, S. R., Taylor, C. C., Kinon, B. J., Breier, A. 2000 The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia Clinical Therapeutics 22 1085 1096 Google Scholar Findling, R. L. 2002 Use of quetiapine in children and adolescents Journal of Clinical Psychiatry 63 27 31 Google Scholar Goyette, C. H., Conners, C. K., Ulrich, R. F 1978 Normative data on revised Conners Parent and Teacher Rating Scales Journal of Abnormal Child Psychology 6 221 236 Google Scholar
Guy W., (1976).
ECDEU Assessment Manual of Psychopharmacology. Rockville, MD: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs Kleinberg, D. L., Davis, J. M., Coster, R., Baelen, B., Brecher, M. 1999 Prolactin levels and adverse events in patients treated with risperidone Journal of Clinical Psychopharmacology 19 57 61 Google Scholar Malone, R. P., Ernst, M., Godfrey, K. A., Locascio, J. J., Campbell, M. 1991 Repeated episodes of neuroleptic-related dyskinesias in autistic children Psychopharmacology Bulletin 27 113 117 Google Scholar Martin, A., Koenig, K., Scahill, L., Bregman, J. 1999 Open-label quetiapine in the treatment of children and adolescents with autistic disorder Journal of Child Adolescent Psychopharmacology 9 99 107 Google Scholar McConville, B. J., Arvanitis, L. A., Thyrum, P. T., Yeh, C., Wilkinson, L. A., Chaney, R. O., et al. 2000 Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: An open-label trial in adolescents with psychotic disorders Journal of Clinical Psychiatry 61 252 260 Google Scholar Research Units on Pediatric Psychopharmacology Autism Network 2002 Risperidone in children with autism and serious behavioral problems New England Journal of Medicine 347 314 321 Google Scholar Sadock, B. J., Sadock, V. A., Kaplan, H. I. 2001Kaplan & Sadock’s pocket handbook of clinical psychiatry (3rd ed.) Lippincott Williams & Wilkins Philadelphia Google Scholar Shaw, J. A., Lewis, J. E., Pascal, S., Sharma, R. K., Rodriguez, R. A., Guillen, R., et al. 2001 A study of quetiapine: Efficacy and tolerability in psychotic adolescents Journal of Child Adolescent Psychopharmacology 11 415 424 Google Scholar Taylor, D. M., McAskill, R. 2000 Atypical antipsychotics and weight gain – a systematic review Acta Psychiatrica Scandinavica 101 416 432 Google Scholar Copyright information
© Springer Science+Business Media, Inc. 2005